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The present study was undertaken to clarify the prevalence and clinicopathological features of synchronous multiple primary
cancers (SMPCs) under upper gastrointestinal endoscopic examination. We enrolled 45,032 consecutive patients who underwent
upper gastrointestinal endoscopic examination for digestive disease from January 2006 to December 2007 in our hospital and
analyzed the clinicopathological features of SMPCs in esophagus and stomach. SMPCs are deﬁned as two or over two diﬀerent
cancerous lesions developing in the same or other organs within 6 months. SMPCs were identiﬁed in 46 patients (0.1%). The
gender ratio was 5.6:1 (male/female) and the mean age was 59.4 years. Synchronous esophageal and gastric cancers were the
most frequent, being seen in 32 patients (0.07%). The most common histological types of SMPCs were squamous cell carcinoma
in esophagus and adenocarcinoma in stomach, respectively. There were 27 (59%) SMPCs patients who had the history of
simultaneous exposure to tobacco smoking and alcohol drinking. Additionally, 32 (78%) esophageal squamous cell cancers were
associated with tobacco use. And 23 adenocarcinomas of the stomach were associated with Helicobacter pylori infection.
1.Introduction
In China, gastric cancer remains the ﬁrst cause of mor-
tality of cancer-related death. Meanwhile the incidence of
esophageal cancer which happens in China accounts for the
highest morbidity worldwide [1]. With the advance in upper
gastrointestinal endoscopic technology combined with the
detailed pathological examinations of biopsy specimens,
the synchronous multiple primary cancers (SMPCs) in
esophagus and stomach therefore have been increasingly
detected, resulting in an increase in the incidence.
According to the criterion of Warren and Gates [2],
t h eS M P C sa r ed e ﬁ n e da st w oo ro v e rt w od i ﬀerent
cancerous lesions developing in the same or other organs
synchronously. Although the number of reports of MPCs in
esophagus and stomach is growing [3–6], very few described
the prevalence and clinicopathological features of SMPCs
under upper gastrointestinal endoscopic examination, espe-
cially from China—high-risk region for both esophageal
and stomach cancers. We, herein, reported a case series
using a database that included a total of 45,032 consecutive
patients who underwent upper gastrointestinal endoscopic
examination for upper gastrointestinal diseases and analyzed
the clinicopathological features of SMPCs in esophagus and
stomach.
2.MaterialandMethods
A total of 45,032 consecutive patients who underwent upper
gastrointestinal endoscopic examination for digestive disease
from January 2006 to December 2007 at the Endoscopy Cen-
ter of West China Hospital, Sichuan University (Chengdu)
were enrolled in this study.
Endoscopic examination of the esophagus, stomach, and
duodenum was performed with video endoscopes (Lucera,
CV-260SL, Olympus, Japan) by experienced endoscopists.
According to Japanese classiﬁcation, esophageal cancers
were divided into four types depending on the lesion’s
macroscopic appearance: fungating, ulcerating, inﬁltrating,2 Gastroenterology Research and Practice
and polypoid. Endoscopic gross pathologic presentations of
early gastric cancers are classiﬁed according to the criteria
proposed by Japanese Society for Gastroenterology as type
I (protruded), type II (including IIa superﬁcial elevated, IIb
superﬁcial ﬂat, type IIc superﬁcial depressed), and type III
(excavated). For the advanced gastric cancer, the Borrmann
classiﬁcation was applied to describe the gross appearance.
Borrmann type I represents polypoid or fungating lesions;
type II is ulcerating lesions surrounded by elevated borders;
typeIIIrepresentsulceratinglesionswithinﬁltrationintothe
gastric wall; type IV is diﬀusely inﬁltrating lesions; type V is
lesions that do not ﬁt into any of the other categories.
Biopsy specimens were taken from all focal lesions. One
specimen from the antrum was used for determination of
Helicobacter pylori (HP) status by the rapid urease test. The
biopsy specimens were ﬁxed in 10% buﬀered formalin or
95% ethanol, embedded in paraﬃn, cut in 5-mm sections,
and stained with hematoxylin and eosin. All specimens
were evaluated by a single pathologist who was blinded to
the clinical characteristics of the patients. All the patients
were interviewed to obtain information on smoking status,
drinking status, and past medical history by questionnaires.
As a regular follow-up program for patients with esophagus
cancer or gastric cancer, a combination of blood chemistry
test, chest X-ray, upper gastrointestinal endoscopy, and
thoracic/abdominal CT was performed.
Multiple primary cancers were deﬁned according to
the criteria of Warren and Gates: (1) all cancers must be
malignant as determined by histologic evaluation; (2) each
cancer must be geographically separate and distinct, and the
lesions should be separated by normal-appearing mucosa;
(3) metastasis cancer must be diﬀerentiated from multiple
primary cancers and ruled out. SMPCs were deﬁned as these
cancers diagnosed within 6 months.
3. Results
3.1. Characteristics of SMPCs. Of the 45,032 patients who
underwent upper gastrointestinal endoscopic examination,
SMPCs were detected in 46 patients (0.1%). In the 46
patients with SMPCs, 39 patients were males, 7 were females
(gender ratio of 5.6:1), and the average age of the patients
with MPC was 59.4 (range 45–76 years).
3.2. Sites of SMPCs. The sites of SMPCs are summarized in
Table 1. In our study, synchronous esophageal and gastric
cancers were the most frequent, being seen in 32 patients
(0.07%),including7inesophagusandcardia,1inesophagus
and fundus, 11 in esophagus and body, 6 in esophagus and
stomach angle, and 7 in esophagus and pylorus. We also
found that 14 patients had the double primary esophageal
cancer.
3.3. Endoscopic Gross Pathologic Presentations of SMPCs. In
total, we found 60 lesions in esophagus which could be clas-
siﬁedintermsofgastroscopicgrosspathologicpresentations:
24 fungating lesions, 16 ulcerating lesions, 19 inﬁltrating
lesions, and 1 polypoid lesion. There were 10 cases of early





Upper Middle Low Total
Stomach 32
C a r d i a 2327
Fundus 0 1 0 1
Body 1 6 4 11
Angle 0 2 4 6
Pylorus 0 4 3 7
Esophagus
Upper 0 1 2 3
M i d d l e 0134
Low 1 4 2 7
Total 4 22 20 92






Squamous cell carcinoma 53 4
Adenosquamous cell
carcinoma 01
Signet ring cell 0 1
Undiﬀerentiated 1 1
gastriccancers(4IIclesionsand6IIIlesions)and22casesof
advanced gastric cancers (7 Borrmann I lesions, 8 Borrmann
II lesions and 7 Borrmann III lesions).
3.4. Histology of SMPCs. The histologic ﬁndings revealed 53
cases of squamous cell carcinomas, 6 of adenocarcinomas
and 1 of undiﬀerentiated in esophagus; 25 of adenocarcino-
mas, 4 of squamous cell carcinomas, 1 of adenosquamous
cell carcinoma, 1 of undiﬀerentiated, and 1 of signet ring
cell carcinoma in stomach (Table 2). These lesions were
localized at cardia (squamous cell carcinoma, n = 3),
fundus (squamous cell carcinoma, n = 1), and body
(adenosquamous, n = 1). The synchronous cancer of cardia
c a r c i n o m a sw e r el o c a t e da tu p p e r( n = 1) and middle
(n = 2 )e s o p h a g u sa n dw e r es q u a m o u sc e l lc a r c i n o m a s .T h e
synchronous cancer of fundus cancer was located at middle
esophagus and was also squamous cell carcinoma. The syn-
chronous cancer of gastric adenosquamous carcinoma was
locatedatmiddleesophagusandwasadenocarcinoma.There
were 11 SMPCs patients (11/14) with the same histology
(squamous cell carcinoma) and 3 patients with diﬀerent
histology(squamouscellcarcinomaandadenocarcinoma)in
double primary esophageal cancer. In addition, there were 7
SMPCs (7/32) with the same histology in diﬀerent organs: 4
of squamous cell carcinomas and 3 of adenocarcinomas.Gastroenterology Research and Practice 3
3.5. Tobacco Smoking, Alcohol Drinking, and Hp Infection
in SMPCs. We found 35 ever-smokers (76%) and 32 ever-
drinkers (70%) in patients with SMPCs. The number of
cigarettes taken by ever-smokers per day was 18.6 ± 6.5. The
daily ethanol intake was 56.6 ± 41.7g. There were 27 (59%)
SMPCs patients who had the history of simultaneous expo-
sure to tobacco smoking and alcohol drinking. Additionally,
32 (78%) esophageal squamous cell cancers were associated
with tobacco use. We detected 38 (83%) SMPCs patients
with HP infection. In these cases, 23 adenocarcinomas of the
stomach were associated with HP infection.
4. Discussion
Ever since Billroth, quoted by Boice et al. [7], reported the
existence of double successive cancers in the same patient in
1889, the MPCs in esophagus and stomach have become no
longer rare. Yoshino et al. [3], in the ﬁrst research of MPCs
patientswithgastriccancer,reportedthatthegastrointestinal
tract, including esophageal (3rd place), is the most common
site of multiple combined with gastric cancer. In another
study, 4 of 2,509 gastric cancer patients (incidence 0.2%)
were found to have primary esophageal cancers [4]. For
the esophageal cancer, gastric cancer is the most common
second primary cancer according to a series of reports. The
incidence of esophageal cancer that coincides with gastric
cancer, reported by several authors, varies between 1.4%
and 5.2%. In the present study, we found 32 patients with
SMPCs in esophagus and stomach (0.07%, 32/45032). There
are two reasons for relatively low relevance ratio in our
study: (1) the previous investigation population was patients
with esophageal or stomach cancer, on the other hand
we collected patients who underwent upper gastrointestinal
endoscopic examination; (2) we did not enroll the patients
with metachronous MPCs.
The patients with SMPCs in esophagus and stomach
were found more often to be male and elderly. These results
were consistent with those of previous studies [4–6]. In
this paper, the gender ratio was 5.6:1 (male/female) and
the mean age was 59.4 years in the patients with SMPCs
of esophagus and stomach. Although little is known of the
deﬁnitecausesofSMPCs,anumberofstudieshavedescribed
SMPCs as the result of interaction between genetic factors
of the host together with dietary and other risk factors in
the environment. We detected 38 (83%) SMPCs patients
with HP infection. In these cases, 23 adenocarcinomas of
the stomach were associated with HP infection. However,
this result must be interpreted with caution, because the
prevalence rate of HP infection may be underestimated
by the rapid urease test. Our results showed that 59%
SMPCs patients had the history of simultaneous exposure to
tobacco smoking and alcohol drinking. Recently, reviews of
epidemiological evidence lent strong support to the eﬀects
of smoking and alcohol consumption in the development
of MPCs [8]. This view is supported by Wen et al. [9]
who pointed out that Northern China, the formerly known
esophageal cancer epidemic region, was actually a high-
risk region for both esophageal and stomach cancers.
These similar geographic distributions suggested that the
environmental risk factors, including tobacco and alcohol,
have the common carcinogenetic eﬀect to the whole upper
gastrointestinal tract.
Through the observation of endoscopic presentations
combined with surgical specimens, we found esophageal
lesions were more severe and more extensive than stomach.
Patients, who usually had solid food dysphagia which
appearedearlierthanstomachsymptoms,visitedthehospital
and received the endoscopic examination. These situations
may result in increased possibility of missing the lesions
beneath esophagus.
5. Conclusions
SMPCs in esophagus and stomach were found in 0.1% of
the patients who underwent upper gastrointestinal endo-
scopic examination. The most common histological types
of SMPCs were squamous cell carcinoma in esophagus and
adenocarcinoma in stomach, respectively.
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